NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT02300935 2019-05-30Study of Trametinib and Nab-paclitaxel in Patients With MelanomaSCRI Development Innovations, LLCPhase 1 Withdrawn
NCT00093119 2017-04-26Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCelgenePhase 2 Completed75 enrolled